secwatch / observer
8-K filed October 3, 2024, 7:59 PM ET ticker KYNB CIK 0000921299
other material confidence high sentiment neutral materiality 0.60

FibroGen terminates headquarters lease, accelerates expiration to Dec 31, 2024, with $10M settlement

KYNTRA BIO, INC.

KYNTRA BIO, INC. filing history →

Source: SEC EDGAR
accession 0000950170-24-112331
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.